Cargando…

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

OBJECTIVE: To identify a core set of domains (outcomes) to be measured in psoriatic arthritis (PsA) clinical trials that represent both patients' and physicians' priorities. METHODS: We conducted (1) a systematic literature review (SLR) of domains assessed in PsA; (2) international focus g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orbai, Ana-Maria, de Wit, Maarten, Mease, Philip, Shea, Judy A, Gossec, Laure, Leung, Ying Ying, Tillett, William, Elmamoun, Musaab, Callis Duffin, Kristina, Campbell, Willemina, Christensen, Robin, Coates, Laura, Dures, Emma, Eder, Lihi, FitzGerald, Oliver, Gladman, Dafna, Goel, Niti, Grieb, Suzanne Dolwick, Hewlett, Sarah, Hoejgaard, Pil, Kalyoncu, Umut, Lindsay, Chris, McHugh, Neil, Shea, Bev, Steinkoenig, Ingrid, Strand, Vibeke, Ogdie, Alexis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344772/ https://www.ncbi.nlm.nih.gov/pubmed/27613807 http://dx.doi.org/10.1136/annrheumdis-2016-210242

Ejemplares similares

Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set
por: Kalyoncu, Umut, et al.
Publicado: (2016)

Classification and Outcome Measures for Psoriatic Arthritis
por: Leung, Ying Ying, et al.
Publicado: (2018)

Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies
por: Orbai, Ana-Maria, et al.
Publicado: (2021)

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)
por: Orbai, Ana-Maria, et al.
Publicado: (2020)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2023)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study
por: Leung, Ying Ying, et al.
Publicado: (2023)

Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
por: Mease, Philip J, et al.
Publicado: (2022)

Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
por: Eder, Lihi, et al.
Publicado: (2023)

Treatment guidelines in psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study
por: Dures, Emma, et al.
Publicado: (2017)

Correction to: Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study
por: Dures, Emma, et al.
Publicado: (2019)

Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients
por: Dures, Emma, et al.
Publicado: (2019)

Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis
por: Polachek, Ari, et al.
Publicado: (2019)

The association between sonographic enthesitis and radiographic damage in psoriatic arthritis
por: Polachek, Ari, et al.
Publicado: (2017)

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries
por: Lucasson, Florian, et al.
Publicado: (2022)

Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
por: Mease, Philip, et al.
Publicado: (2022)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
por: Helliwell, Philip S, et al.
Publicado: (2022)

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
por: Mease, Philip J., et al.
Publicado: (2020)

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research
por: van der Heijde, Désirée, et al.
Publicado: (2020)

Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
por: Karmacharya, Paras, et al.
Publicado: (2021)

Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
por: Gladman, Dafna, et al.
Publicado: (2020)

Smoking, environmental tobacco smoke, and risk of renal cell cancer: a population-based case-control study
por: Theis, Ryan P, et al.
Publicado: (2008)

Training and delivery of a novel fatigue intervention: a qualitative study of rheumatology health-care professionals’ experiences
por: Dures, Emma, et al.
Publicado: (2019)

Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study
por: Coates, Laura C, et al.
Publicado: (2023)

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study
por: Tillett, William, et al.
Publicado: (2023)

Exploring the illness representations of people with psoriatic arthritis: a secondary analysis of focus group data
por: Erskine, George, et al.
Publicado: (2018)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis
por: Gladman, Dafna D., et al.
Publicado: (2019)

The experience of foot problems and decisions to access foot care in patients with rheumatoid arthritis: a qualitative study
por: Wilson, Oonagh, et al.
Publicado: (2017)

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT
por: Gladman, Dafna D, et al.
Publicado: (2010)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
por: Coates, Laura C, et al.
Publicado: (2020)

A Crowdsourcing Open Contest to Design a Latino-Specific COVID-19 Campaign: Mixed Methods Analysis
por: Shah, Harita S, et al.
Publicado: (2022)

Recent advances in understanding and managing psoriatic arthritis
por: Gladman, Dafna D.
Publicado: (2016)

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
por: Mease, Philip J, et al.
Publicado: (2017)

Sólo Se Vive Una Vez: Evaluation of a Social Marketing Campaign Promoting HIV Screening and Prevention for Immigrant Latinxs
por: Shah, Harita S., et al.
Publicado: (2021)

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study
por: Smolen, Josef S, et al.
Publicado: (2019)

Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study
por: Perez-Chada, Lourdes M., et al.
Publicado: (2021)

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
por: Cappelli, Laura C., et al.
Publicado: (2020)

HIV-related stigma among Spanish-speaking Latinos in an emerging immigrant city following the Solo Se Vive Una Vez social marketing campaign
por: Grieb, Suzanne M. Dolwick, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j3p37pttb2oo9aqfducmrncutf